Physician profile
Haroon Mian
NPI 1326210899
$908.72
in general payments reported to CMS, 2019-2025
14 companies · $40.16 in 2025
The $40.16 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.82 · 2021: $96.81 · 2022: $46.27 · 2023: $221 · 2024: $410 · 2025: $40.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $414.72 | 2019-2025 | Farxiga, Airsupra |
| Teleflex LLC | $96.81 | 2021 | |
| Pfizer INC. | $64.66 | 2019-2024 | |
| Alkermes, INC. | $53.13 | 2023 | Vivitrol |
| Exact Sciences Corporation | $52.20 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $42.57 | 2022-2024 | |
| Medtronic, INC. | $34.62 | 2024 | Intellis Adaptivestim |
| Lilly USA, LLC | $29.87 | 2019-2025 | Zepbound, Mounjaro |
| Braeburn INC. | $29.55 | 2024 | Brixadi |
| Nevro Corp. | $26.75 | 2024 | Senza |
| Dexcom, INC. | $22.18 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $16.31 | 2024 | Rotarix, Pediarix, Bexsero |
| Amgen INC. | $15.73 | 2019 | |
| Linus Health, INC. | $9.62 | 2024 | Core Cognitive Evaluation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haroon Mian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.